Health Policy
WHO guidelines, EU directives, and Georgian health governance
UK’s Healthy Life Expectancy Falls: Is the NHS Struggling to Keep People Well?
The UK's healthy life expectancy has stalled or declined, with people living longer but spending more years with chronic disease…
Editor's Top Picks
Biotech M&A Accelerates: AbbVie’s Apogee Deal Signals Return of Major Acquisitions
AbbVie's acquisition of Apogee Therapeutics marks a significant return to biotech M&A activity after an extended sector slowdown. Recent positive…
Submit Your Paper →
More form Health Policy
A Father’s Fight: How One Family’s Quest Is Reshaping Rare Disease Drug Development
A father's advocacy for his daughter with ultra-rare NGLY1 deficiency is reshaping how experimental gene…
Obesity as disease: Who profits from the classification shift?
Max Moser argues in STAT News that obesity's reclassification as a disease has accelerated pharmaceutical…
Cancer’s Hidden Cost: How Oncology Must Rethink Toxicity Monitoring
Modern cancer drugs extend survival, but oncology's toxicity monitoring systems—designed for acute effects during treatment—fail…
WHO Breast Cancer Survival Targets: New Global Benchmarks Reveal Progress and Persistent Inequities
New benchmark estimates from Nature Medicine (2026) show breast cancer five-year survival rates across all…
WHO projects cancer cases to nearly double by 2050 without urgent prevention action
The World Health Organization warns that global cancer cases could nearly double to 35 million…